AI Verdict
IBTA has stronger fundamentals based on our AI analysis.
ICUCW vs IBTA Fundamental Comparison
| Metric | ICUCW | IBTA |
|---|---|---|
| Revenue | $1.2M | $342.4M |
| Net Income | $-12.2M | $3.6M |
| Net Margin | -984.6% | 1.0% |
| ROE | -116.6% | 1.2% |
| ROA | -85.8% | 0.7% |
| Current Ratio | 3.63x | 1.96x |
| Debt/Equity | 0.05x | 0.00x |
| EPS | $-0.58 | $0.12 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ICUCW vs IBTA: Frequently Asked Questions
Is ICUCW or IBTA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBTA has stronger fundamentals. ICUCW is rated SELL (62% confidence) while IBTA is rated HOLD (68% confidence). This is not investment advice.
How does ICUCW compare to IBTA fundamentally?
SeaStar Medical Holding Corp has ROE of -116.6% vs Ibotta, Inc.'s 1.2%. Net margins are -984.6% vs 1.0% respectively.
Which stock pays higher dividends, ICUCW or IBTA?
ICUCW has a dividend yield of N/A or no dividend while IBTA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ICUCW or IBTA for long term?
For long-term investing, consider that ICUCW has SELL rating with 62% confidence, while IBTA has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ICUCW vs IBTA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ICUCW vs IBTA, the AI consensus favors IBTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.